Connection

Ernest Camp to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Ernest Camp has written about Combined Modality Therapy.
Ernest Camp
Connection Strength
0.122
Combined Modality Therapy
  1. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy. Cancer Gene Ther. 2013 Apr; 20(4):222-8.
    View in: PubMed
    Score: 0.090
  2. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data. Laryngoscope. 2012 Jun; 122(6):1283-90.
    View in: PubMed
    Score: 0.021
  3. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg. 2002 Sep-Oct; 6(5):664-70.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.